In addition to SMN2 copy number variation, other genetic modifiers of SMA have also been described (Hosseinibarkooie et al., 2016; Oprea et al., 2008; Riessland et al., 2017), but up to 40% of variation in disease severity remains genetically unexplained. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.